Metastatic Melanoma

Showing NaN - NaN of 22

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in

Active, not recruiting
  • Metastatic Melanoma
  • +22 more
  • Ipilimumab
  • +3 more
  • Birmingham, Alabama
  • +24 more
Jan 19, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

Active, not recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +20 more
  • Ipilimumab
  • +3 more
  • Tampa, Florida
  • +6 more
Jan 13, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Digestive System Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +12 more
  • Tucson, Arizona
  • +60 more
Jan 11, 2023

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in United States (Dabrafenib Mesylate, Tazemetostat

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Metastatic Melanoma
  • Dabrafenib Mesylate
  • +2 more
  • Atlanta, Georgia
  • +6 more
Nov 30, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in United

Active, not recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +4 more
  • Biospecimen Collection
  • +9 more
  • Birmingham, Alabama
  • +848 more
Aug 24, 2022

Melanoma, Advanced Melanoma, Metastatic Melanoma Trial in United States (CMP-001, Nivolumab)

Active, not recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +24 more
Aug 1, 2022

Melanoma, Advanced Melanoma, Metastatic Melanoma Trial in United States (CMP-001, Nivolumab)

Active, not recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +19 more
Aug 1, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Acral Lentiginous Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma Trial in United States

Recruiting
  • Acral Lentiginous Melanoma
  • +6 more
  • Birmingham, Alabama
  • +309 more
Nov 8, 2021

Advanced Cancer, Metastatic Melanoma, Metastatic NSCLC Trial in Worldwide (LY3214996, Midazolam, Abemaciclib)

Active, not recruiting
  • Advanced Cancer
  • +3 more
  • Washington, District of Columbia
  • +12 more
Sep 2, 2021

Metastatic Melanoma Trial in Worldwide (MORAb-004 (mAb))

Completed
  • Metastatic Melanoma
  • MORAb-004 (monoclonal antibody)
  • Scottsdale, Arizona
  • +28 more
Aug 6, 2021

Metastatic Melanoma Trial in Worldwide (Lifileucel)

Active, not recruiting
  • Metastatic Melanoma
  • Lifileucel
  • La Jolla, California
  • +56 more
Mar 24, 2021

Metastatic Melanoma Trial in United States (vemurafenib + HD IL-2)

Terminated
  • Metastatic Melanoma
  • vemurafenib + HD IL-2
  • Tucson, Arizona
  • +20 more
Jan 28, 2021

Metastatic Melanoma Trial in Switzerland, United States (RAF265)

Completed
  • Metastatic Melanoma
  • Aurora, Colorado
  • +10 more
Dec 11, 2020

Metastatic Melanoma Trial in Pittsburgh (DC vaccine, Dasatinib)

Completed
  • Metastatic Melanoma
  • Pittsburgh, Pennsylvania
    Hillman Cancer Center
Aug 12, 2019

Treatment Patterns and Clinical Response in Malignancy

Completed
  • Metastatic Renal Cell Carcinoma
  • Metastatic Melanoma
    • Tucson, Arizona
    • +44 more
    Jun 11, 2019

    Metastatic Melanoma, Recurrent Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in United States (Aldesleukin, Laboratory

    Completed
    • Metastatic Melanoma
    • +6 more
    • Aldesleukin
    • +2 more
    • Duarte, California
    • +20 more
    May 9, 2019

    Metastatic Melanoma Trial in Australia, United States (tasisulam)

    Completed
    • Metastatic Melanoma
    • Los Angeles, California
    • +12 more
    May 4, 2018

    Metastatic Melanoma, Cutaneous Melanoma Trial in Chicago, Pittsburgh (HDI, KW2871)

    Completed
    • Metastatic Melanoma
    • Cutaneous Melanoma
    • Chicago, Illinois
    • +1 more
    Feb 19, 2018

    Melanoma, Metastatic Melanoma Trial in United States (Vemurafenib, Bevacizumab, Cobimetinib)

    Terminated
    • Melanoma
    • Metastatic Melanoma
    • Los Angeles, California
    • +13 more
    Sep 22, 2017

    Metastatic Melanoma Trial in Pittsburgh (Vaccination)

    Terminated
    • Metastatic Melanoma
    • Vaccination
    • Pittsburgh, Pennsylvania
      Upmc Upci Hcc
    Jul 16, 2017

    Metastatic Melanoma Trial in United States (IPI-504)

    Terminated
    • Metastatic Melanoma
    • Tuscon, Arizona
    • +16 more
    Dec 6, 2012